BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18995957)

  • 1. Myricetin directly targets JAK1 to inhibit cell transformation.
    Kumamoto T; Fujii M; Hou DX
    Cancer Lett; 2009 Mar; 275(1):17-26. PubMed ID: 18995957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 Cl 41 cells.
    Ichimatsu D; Nomura M; Nakamura S; Moritani S; Yokogawa K; Kobayashi S; Nishioka T; Miyamoto K
    Mol Carcinog; 2007 Jun; 46(6):436-45. PubMed ID: 17219438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin.
    Kim JE; Kwon JY; Lee DE; Kang NJ; Heo YS; Lee KW; Lee HJ
    Biochem Pharmacol; 2009 Feb; 77(3):412-21. PubMed ID: 19026990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3.
    Kim NH; Lee MY; Park SJ; Choi JS; Oh MK; Kim IS
    Immunology; 2007 Dec; 122(4):607-14. PubMed ID: 17645497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chrysin suppresses IL-6-induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: an in vitro and in ovo approach.
    Lin CM; Shyu KG; Wang BW; Chang H; Chen YH; Chiu JH
    J Agric Food Chem; 2010 Jun; 58(11):7082-7. PubMed ID: 20443595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1.
    Lee KW; Kang NJ; Rogozin EA; Kim HG; Cho YY; Bode AM; Lee HJ; Surh YJ; Bowden GT; Dong Z
    Carcinogenesis; 2007 Sep; 28(9):1918-27. PubMed ID: 17693661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of myricetin and related flavonols against A2E and light mediated-cell death in bovine retinal primary cell culture.
    Laabich A; Manmoto CC; Kuksa V; Leung DW; Vissvesvaran GP; Karliga I; Kamat M; Scott IL; Fawzi A; Kubota R
    Exp Eye Res; 2007 Jul; 85(1):154-65. PubMed ID: 17544396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myricetin is a potent chemopreventive phytochemical in skin carcinogenesis.
    Kang NJ; Jung SK; Lee KW; Lee HJ
    Ann N Y Acad Sci; 2011 Jul; 1229():124-32. PubMed ID: 21793847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical structure of flavonols in relation to modulation of angiogenesis and immune-endothelial cell adhesion.
    Kim JD; Liu L; Guo W; Meydani M
    J Nutr Biochem; 2006 Mar; 17(3):165-76. PubMed ID: 16169200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licochalcone A is a potent inhibitor of TEL-Jak2-mediated transformation through the specific inhibition of Stat3 activation.
    Funakoshi-Tago M; Tago K; Nishizawa C; Takahashi K; Mashino T; Iwata S; Inoue H; Sonoda Y; Kasahara T
    Biochem Pharmacol; 2008 Dec; 76(12):1681-93. PubMed ID: 18848530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: possible mediation by blocking the ERK signaling pathway.
    Shih YW; Wu PF; Lee YC; Shi MD; Chiang TA
    J Agric Food Chem; 2009 May; 57(9):3490-9. PubMed ID: 19326946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells.
    Cascio S; Ferla R; D'Andrea A; Gerbino A; Bazan V; Surmacz E; Russo A
    J Cell Physiol; 2009 Oct; 221(1):189-94. PubMed ID: 19492417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling.
    Richter M; Ebermann R; Marian B
    Nutr Cancer; 1999; 34(1):88-99. PubMed ID: 10453447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway.
    Weissenberger J; Priester M; Bernreuther C; Rakel S; Glatzel M; Seifert V; Kögel D
    Clin Cancer Res; 2010 Dec; 16(23):5781-95. PubMed ID: 21138870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK1 N-terminus binds to conserved Box 1 and Box 2 motifs of cytokine receptor common beta subunit but signal activation requires JAK1 C-terminus.
    Huang HM; Lee YL; Chang TW
    J Cell Biochem; 2006 Nov; 99(4):1078-84. PubMed ID: 16767694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor induces delayed STAT3 phosphorylation through interleukin-6 expression.
    Lee BS; Park M; Cha HY; Lee JH
    Cell Signal; 2009 Mar; 21(3):419-27. PubMed ID: 19071214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
    Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine production through PKC/p38 signaling pathways, not through JAK/STAT1 pathway, in mast cells stimulated with IFNgamma.
    Seo JY; Kim DY; Lee YS; Ro JY
    Cytokine; 2009 Apr; 46(1):51-60. PubMed ID: 19231233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK pathway induction of c-Myc critical to IL-5 stimulation of cell proliferation and inhibition of apoptosis.
    Lee WH; Liu FH; Lin JY; Huang SY; Lin H; Liao WJ; Huang HM
    J Cell Biochem; 2009 Apr; 106(5):929-36. PubMed ID: 19180571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt is a direct target for myricetin to inhibit cell transformation.
    Kumamoto T; Fujii M; Hou DX
    Mol Cell Biochem; 2009 Dec; 332(1-2):33-41. PubMed ID: 19504174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.